Metraipolis › archive › dc_e8497bbdd724

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study… — Europe PMC PMID:36384890

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36384890
DOI
10.1136/bmj-2022-071932
License (as archived)
solo-consultazione
Archived
2026-10-08T01:13:12.853Z
SHA-256 of the archived text
9713be69aee0ad734ac825bbc64e87ef937570b4f39ef72eff2d72f98551f0ee
Stable URL of this page
https://metraipolis.com/documento/dc_e8497bbdd724

How to cite

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study… — Europe PMC PMID:36384890 — Europe PMC (en), https://europepmc.org/article/MED/36384890 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e8497bbdd724 (Metraipolis archive dc_e8497bbdd724, sha256 9713be69aee0ad734ac825bbc64e87ef937570b4f39ef72eff2d72f98551f0ee)
BibTeX
@misc{dce8497bbdd724,
  title = {Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study… — Europe PMC PMID:36384890},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36384890},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e8497bbdd724; sha256 9713be69aee0ad734ac825bbc64e87ef937570b4f39ef72eff2d72f98551f0ee},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36384890. Agents can read the archived copy with the MCP tool read_document.